Asha Therapeutics Launches as First Atom Therapeutics, a Zero-Shot De Novo Drug Design Company
Asha Therapeutics has announced its rebranding as First Atom Therapeutics (“First Atom”), marking the company’s evolution as a zero-shot de novo drug design company using AI-enabled molecular design technology to create transformative medicines for neurodegenerative, neuro-oncological, and rare diseases.
